glp-1 brain inflammation Frontiers Mechanisms of GLP-1 in Modulating

Nutrition Support: Eating Well on GLP-1 Medications As your appetite changes, ensuring proper nutrition becomes increasingly important

Here's the current landscape: Brand Name Oral Semaglutide (Wegovy pill): Novo Nordisk announced a limited-time price of $149/month for the starting dose Higher doses (25mg) may cost more Launched in January 2026 Additional costs may apply such as labs, consultations, shipping and membership Brand Name Injectable GLP-1s: Wegovy: $1,000-1,500/month without insurance Ozempic: $900-1,000/month without insurance Mounjaro/Zepbound: $1,000-1,400/month without insurance Compounded Injectable GLP-1s: Affinity Whole Health: Starting at $299/month for compounded semaglutide Includes medications, supplies, shipping, and ongoing support Significant savings compared to brand names Compounded ODT Formulations: Prices vary widely, typically $299-449/month for compounded semaglutide or tirzepatide ODTs Generally more expensive than compounded injectables Available through compounding pharmacies Currently, compounded injectable medications from FDA-registered facilities remain the most cost-effective option for most patients seeking GLP-1 therapy

doi:10.1530/JOE-10-0419 47

Strong eligibility across virtually all pathways

Practical Considerations for Prescribers When planning treatment strategies in 2026, its important to address the side effects of metformin, its affordability, and how it compares to newer medications in patient-specific contexts